Full-Time

Senior Director

Marketing, Sleep

Posted on 4/27/2024

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops therapies for central nervous system conditions

Biotechnology

Senior

New York, NY, USA

Required Skills
Sales
Marketing
Data Analysis
Requirements
  • BA or BS; MBA or other advanced degree preferred
  • At least 8 years of experience in pharmaceutical/biotechnology marketing, with a significant portion (5-7 years) dedicated to executing successful HCP facing marketing campaigns
  • Previous involvement with CNS disorders or product launches in this domain is highly preferred
  • Ability to work on site Monday, Tuesday & Thursday. We are unable to consider candidates who are looking for fully remote roles
Responsibilities
  • Lead the in-line brand of SUNOSI including the integrated brand plan, create programs and tactics to support the strategy, and execute the tactical marketing plans on HCP audiences
  • Lead the development of the marketing plans for AXS-12 Narcolepsy and champion the plan through engagement with internal and external partners
  • Identify appropriate measurements & ROI, and develop comprehensive reporting to evaluate effectiveness of tactical efforts
  • Oversee key agency relationships, ensuring alignment with marketing objectives and efficient budget utilization
  • Lead reviews of promotional materials with Regulatory/Legal/Medical
  • Partner effectively with sales, market access, market research, medical affairs, commercial operations, data & analytics, finance, and other cross-functional partners
  • Identify strategic market opportunities and make recommendations to enhance brand performance
  • Efficiently manage budgets and timelines according to the brand plan, ensuring timely delivery of marketing initiatives
  • Undertake additional tasks as required, contributing to the team’s success.

Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

With a dedicated focus on developing therapies for central nervous system conditions—such as depression, Alzheimer’s disease agitation, and fibromyalgia—this company stands out by addressing critical unmet medical needs with promising products like AXS-05 and AXS-07. The firm fosters a culture deeply committed to innovation and the development of therapies with novel mechanisms of action, showcasing strong potential in the medical field and enhancing patient care in areas with limited treatment options.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

12%

1 year growth

45%

2 year growth

277%
INACTIVE